Log in or Sign up for Free to view tailored content for your specialty!
Pediatrics Strabismus News
Seeing the progress of research in the eyes of a child
Holding a family’s fragile, premature newborn is a humbling moment — especially as a newly minted doctor.
Setting expectations, postop care ‘crucial’ in pediatric retinal repair
NEW YORK — A focus on follow-up care and monocular precautions may help improve outcomes in pediatric patients undergoing retinal repair, according to a presenter at OSN New York Retina.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Vision training software treats amblyopia in children, adults
BOSTON – RevitalVision is a prescribed vision training software that stimulates the brain’s visual cortex to improve vision in patients with amblyopia from the age of 9 years through adulthood, RevitalVision founder and CEO, Yair Yahav, said here at the American Academy of Optometry annual meeting.
FDA issues premarket approval for novel digital amblyopia therapy
The FDA has granted de novo premarket approval for Luminopia One, a digital therapy for children aged 4 to 7 years with amblyopia, according to a press release from Luminopia.
OCT study shows effect of eye rubbing in children’s corneas
An anterior segment OCT study showed that the corneas of children who frequently rub their eyes have abnormal epithelial thickness distribution, with thinning in the inferotemporal area on the dominant-hand side.
Extra steps can make a pediatric ophthalmology exam successful
Examining a child may be a daunting process for a comprehensive ophthalmologist.
Consider long-term goals when choosing ophthalmology fellowship program
A speaker at the Real World Ophthalmology meeting offered advice on choosing the right fit and making the most out of an ophthalmology fellowship program.
Novel digital therapy for amblyopia demonstrates positive phase 3 results
Luminopia One, an investigational digital therapy that allows patients with amblyopia to watch visually modified TV shows and movies to improve vision, has shown positive results, according to a press release from Luminopia.
Santen, Sydnexis reach licensing agreement for atropine formulation
Santen and Sydnexis have finalized an exclusive licensing agreement for SYD-101 in Europe, Middle East and Africa for the treatment of progressive childhood myopia, according to a press release.
Treatment of progressive myopia needs to begin as early as possible
Drug shortage, including ophthalmic eye drops, is becoming a meaningful problem for doctors and patients, especially for generic eye drops in which there is minimal financial incentive to the manufacturer.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read